Sanctuary Advisors LLC Buys Shares of 36,664 Tilray Inc (NASDAQ:TLRY)

Sanctuary Advisors LLC bought a new position in Tilray Inc (NASDAQ:TLRY) in the second quarter, Holdings Channel.com reports. The institutional investor bought 36,664 shares of the company’s stock, valued at approximately $65,000.

Other hedge funds have also modified their holdings of the company. Tidal Investments LLC increased its holdings in shares of Tilray by 36,687.0% in the first quarter. Tidal Investments LLC now owns 10,677,428 shares of the company’s stock valued at $26,373,000 after purchasing an additional 10,648,403 shares during the period. Bank of Montreal Can raised its holdings in Tilray by 19.6% in the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after purchasing an additional 355,778 shares during the period. Virtu Financial LLC acquired a new stake in Tilray in the 1st quarter valued at $586,000. Mirae Asset Global Investments Co. Ltd. raised its position in shares of Tilray by 8.7% during the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 2,679,532 shares of the company’s stock worth $6,699,000 after purchasing an additional 213,834 shares during the last quarter. Finally, J.W. Cole Advisors Inc. boosted its stake in shares of Tilray by 1,077.2% in the second quarter. J.W. Cole Advisors Inc. now owns 171,054 shares of the company’s stock worth $284,000 after acquiring an additional 156,524 shares during the last quarter. 9.35% of the stock is owned by hedge funds and other institutional investors.

Tilray Trading Down 0.6 %

Shares of TLRY stock opened at $1.58 on Tuesday. The company has a debt-to-equity ratio of 0.08, a current ratio of 2.47 and a quick ratio of 1.57. The company has a 50-day moving average of $1.73 and a two-hundred day moving average of $1.81. Tilray Inc has a 1-year low of $1.45 and a 1-year high of $2.97. The firm has a market cap of $1.43 billion, a PE ratio of -5.85 and a beta of 2.13.

Tilray (NASDAQ:TLRY) last announced its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, hitting the consensus estimate of ($0.04). Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. The firm had revenue of $200.00 million for the quarter, compared to the consensus estimate of $218.70 million. During the same period in the prior year, the firm earned ($0.10) EPS. The firm’s revenue for the quarter was up 13.0% on a year-over-year basis. On average, analysts predict that Tilray Inc will post -0.14 EPS for the current year.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm dropped their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating for the company in a research report on Friday, October 11th.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.